Coagulation rapid test

INRVKAblood

The LumiraDx INR Test measures prothrombin time reported as International Normalized Ratio (INR) from a single, direct fingerstick blood sample – all in less than 90 seconds*. The Test is used for monitoring patients on oral anticoagulation therapy with Vitamin-K Antagonist (VKA) drugs. Used with the LumiraDx Instrument, the Test delivers rapid results at the point of care. Test benefits INR is the preferred test for monitoring patients on vitamin K antagonist (VKA) therapy. The current standard method for monitoring INR is laboratory testing. However, the LumiraDx INR Test is performed at the point of care, which provides several benefits over laboratory testing. Improved convenience – on the spot testing – at the patient’s side Faster turnaround times when compared to laboratory testing – results in less than 90 seconds* Faster diagnosis and management of treatment leads to improved clinical outcomes Reduced number of referrals – reducing the burden upon secondary care Precise & accurate – CVs <5% and correlation with the Instrumentation Laboratory ACL Elite laboratory reference method Room temperature Test Strip storage Test workflow The Instrument and Test Strips are integrated with several quality control checks to ensure the Instrument and Test are functioning correctly for every test run. The workflow process is comprised of a single fingerstick and direct application to the Test Strip, along with step-by-step guidance of the Instrument to report a patient result. Test performance In the OPTIMAL clinical trial, the LumiraDx INR Test correlated strongly with the Instrumentation Laboratory ACL Elite laboratory reference method.